CAS 460330-27-2

Formel: C30H37N7O2

InChl: InChI=1S/C30H37N7O2/c1-39-25-12-13-27-23(20-25)21-26(30(38)31-27)28(36-18-16-35(17-19-36)24-10-6-3-7-11-24)29-32-33-34-37(29)15-14-22-8-4-2-5-9-22/h2,4-5,8-9,12-13,20-21,24,28H,3,6-7,10-11,14-19H2,1H3,(H,31,38)

InChI Key: ZVWPOIUAPXDLMB-UHFFFAOYSA-N

SMILES: COC1=CC2=C(C=C1)NC(=O)C(=C2)C(C3=NN=NN3CCC4=CC=CC=C4)N5CCN(CC5)C6CCCCC6

GT 949

CAS: 460330-27-2

GT 949

Formel: C₃₀H₃₇N₇O₂

Reinheit: ≥98%

Molekulargewicht: 527.66

Ref: 54-BUP10324

GT 949

CAS: 460330-27-2

Formel: C₃₀H₃₇N₇O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 527.6605

Ref: IN-DA01ENHD

GT 949

CAS: 460330-27-2

GT 949 is a synthetic peptide that has been shown to have neuroprotective properties in vivo and in vitro. GT 949 has been shown to inhibit the accumulation of reactive oxygen species, which are associated with neuronal damage. GT 949 also inhibits the formation of amyloid-β fibrils, which are associated with Alzheimer's disease. This peptide has also been shown to be neuroprotective following glutamate excitotoxicity and prion-induced neurotoxicity. GT 949 may also have potential use as a treatment for Parkinson's disease, because it can block the aggregation of alpha-synuclein oligomers and prevent the formation of Lewy bodies.

Formel: C₃₀H₃₇N₇O₂

Reinheit: Min. 95%

Molekulargewicht: 527.66 g/mol

Ref: 3D-KTA33027

GT 949

CAS: 460330-27-2

GT 949 is a selective excitatory positive allosteric modulator of amino acid transporter-2 (EAAT2) (EC50: 0.26 nM).

Formel: C₃₀H₃₇N₇O₂

Reinheit: 99.95%

Farbe und Form: Solid

Molekulargewicht: 527.6605

Ref: TM-T15446